Symptomatic and Incidental RCC Detection

NCT07004426 | Completed

• 1 other identifier: KIDCaD
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

Evaluation of the frequency of symptomatic and incidental detection of renal carcinoma at different stages depending on the imaging modality used

Conditions

Renal Cell Carcinoma (Kidney Cancer); Benign Renal Neoplasm; Renal Carcinoma

Keywords

Renal cell carcinoma; Detection; Imaging modalities; Non-neoplastic renal lesions

Outcome Measures

Primary Outcomes (1)

• Detection-specific renal cell carcinoma (RCC) proportions

  Detection-specific renal cell carcinoma (RCC) proportions, defined as the proportion of each detection type relative to all RCC cases. Results will be stratified by stage, histological type, and imaging modality.

  From 2011 to 2020

Secondary Outcomes (1)

• Proportion of RCC among neoplastic and non-neoplastic renal lesions

  From 2011 to 2020

Study Arms (1)

A single patient group undergoing intervention for renal lesions

Procedure: Surgical treatment of renal lesions

Interventions

Surgical treatment of renal lesions PROCEDURE

Surgical treatment of renal lesions

A single patient group undergoing intervention for renal lesions

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients treated for renal lesions at the Urology Department of University Hospital Královské Vinohrady

You may qualify if:

• patients over 18 years of age undergoing surgical treatment for renal lesions

You may not qualify if:

• patients undergoing surgery for non-renal and urotelial carcinoma, including unknown
• patients with recurrent renal lesions

Sponsors & Collaborators

• Charles University, Czech Republic: lead
• University Hospital Kralovske Vinohrady: collaborator

Study Sites (1)

University Hospital Královské Vinohrady

Prague, 100 34, Czechia

Location

MeSH Terms

Conditions

Carcinoma, Renal Cell; Kidney Neoplasms

Condition Hierarchy (Ancestors)

Adenocarcinoma; Carcinoma; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type; Neoplasms; Urologic Neoplasms; Urogenital Neoplasms; Neoplasms by Site; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Kidney Diseases; Urologic Diseases; Male Urogenital Diseases

Study Officials

• Jindřich Šonský, MD

  Vascular surgery, University hospital Královské Vinohrady, Prague

  PRINCIPAL INVESTIGATOR

• Alexandra Gregušová, MD

  Vascular surgery, University hospital Královské Vinohrady, Prague

  STUDY CHAIR

• Jakub Hanych, MD

  Vascular surgery, University hospital Královské Vinohrady, Prague

  STUDY CHAIR

• Robert Grill, assoc. prof., MD, PhD

  Vascular surgery, University hospital Královské Vinohrady, Prague

  STUDY DIRECTOR

• Kateřina Licková, MD, PhD

  Vascular surgery, University hospital Královské Vinohrady, Prague

  STUDY CHAIR

• Jana Malinová, MD, PhD

  Vascular surgery, University hospital Královské Vinohrady, Prague

  STUDY CHAIR

• Tomáš Blažek, MD, PhD

  Ostrava University Hospital

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 27, 2025
• First Posted: June 4, 2025
• Study Start: June 1, 2025
• Primary Completion: July 1, 2025
• Study Completion: July 15, 2025
• Last Updated: March 19, 2026

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will share
• Shared Documents: CSR
• Time Frame: planned from August 2025 for a period of 5 years
• Access Criteria: The data that support the findings of this study will be available from the principal investigators upon reasonable request.

Locations

CZ (1)